相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells
Jose Esparza-Lopez et al.
ONCOLOGY LETTERS (2022)
Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells
Merve Erkisa et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis
Alexandra Giatromanolaki et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Chemotherapy-Induced Collagen IV Drives Cancer Cell Motility through Activation of Src and Focal Adhesion Kinase
Jackson P. Fatherree et al.
CANCER RESEARCH (2022)
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
Paola Ferrari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance
Sydney Diep et al.
CELLS (2022)
Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
Maoli Wang et al.
Journal of Oncology (2022)
In Vitro Anti-Proliferative, and Kinase Inhibitory Activity of Phenanthroindolizidine Alkaloids Isolated from Tylophora indica
Ehab M. Mostafa et al.
PLANTS-BASEL (2022)
Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
Shinjit Mani et al.
BIONANOSCIENCE (2022)
Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis
Chang-Hyeon Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Tumor microenvironment promotes breast cancer chemoresistance
Umar Mehraj et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
The role of hypoxia-inducible factor 1 in tumor immune evasion
Li You et al.
MEDICINAL RESEARCH REVIEWS (2021)
Expression pattern analysis and drug differential sensitivity of cancer-associated fibroblasts in triple-negative breast cancer
Qilong Li et al.
TRANSLATIONAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hypoxia in Breast Cancer-Scientific Translation to Therapeutic and Diagnostic Clinical Applications
Ying Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts
Farhana Mollah et al.
BIOMEDICINES (2021)
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
Ute Jungwirth et al.
NATURE COMMUNICATIONS (2021)
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
Umar Mehraj et al.
CELLULAR ONCOLOGY (2021)
Ginsenoside CK Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma
Jingjing Zhang et al.
FOODS (2021)
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Haiyun Zhang et al.
CANCER DRUG RESISTANCE (2021)
Regulation of cancer stem cells in triple negative breast cancer
Norman Fultang et al.
CANCER DRUG RESISTANCE (2021)
Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway
Hao Wu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K. G. K. Deepak et al.
PHARMACOLOGICAL RESEARCH (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
HTBPI, an active phenanthroindolizidine alkaloid, inhibits liver tumorigenesis by targeting Akt
Hongwei Liu et al.
FASEB JOURNAL (2020)
RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression
Mei Wang et al.
CELL COMMUNICATION AND SIGNALING (2020)
Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
Julia Lopez de Andres et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer
K.A. Gaptulbarova et al.
Experimental Oncology (2020)
Pseudopterosin andO-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma
Bailu Xie et al.
BIOENGINEERING-BASEL (2020)
NK007 helps in mitigating paclitaxel resistance through p38MAPK activation and HK2 degradation in ovarian cancer
Zhenhua Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
Betul Gokyavuz et al.
SCIENTIFIC REPORTS (2019)
Tylophorine reduces protein biosynthesis and rapidly decreases cyclin D1, inhibiting vascular smooth muscle cell proliferation in vitro and in organ culture
Helge Joa et al.
PHYTOMEDICINE (2019)
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer
Yulia Liubomirski et al.
FRONTIERS IN IMMUNOLOGY (2019)
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Kha-Liang Lee et al.
CANCERS (2019)
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Ana S. Nunes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database
Ki-Tae Hwang et al.
CLINICAL CANCER RESEARCH (2019)
CoCl2 simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis
Nishant Kumar Rana et al.
BIOLOGICAL RESEARCH (2019)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Advances in the systemic treatment of triple-negative breast cancer
J. M. Lebert et al.
CURRENT ONCOLOGY (2018)
Clinical validation of nuclear factor kappa B expression in invasive breast cancer
Anil Kumar Agrawal et al.
TUMOR BIOLOGY (2018)
Role of the NFκB-signaling pathway in cancer
Longzheng Xia et al.
ONCOTARGETS AND THERAPY (2018)
Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429
Qinglong Guo et al.
CELL DEATH & DISEASE (2018)
The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance
Mitsuyoshi Okazaki et al.
Cancer Management and Research (2018)
Pseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha
Julia Sperlich et al.
MOLECULES (2018)
The role of NFκB in spheroid formation of human breast cancer cells cultured on the Random Positioning Machine
Sascha Kopp et al.
SCIENTIFIC REPORTS (2018)
The Marine Natural Product Pseudopterosin Blocks Cytokine Release of Triple-Negative Breast Cancer and Monocytic Leukemia Cells by Inhibiting NF-κB Signaling
Julia Sperlich et al.
MARINE DRUGS (2017)
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
Basel Abu-Jamous et al.
MOLECULAR CANCER (2017)
Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
Hasini Jayatilaka et al.
NATURE COMMUNICATIONS (2017)
Metabolic Cooperation and Competition in the Tumor Microenvironment: implications for Therapy
Seema Gupta et al.
FRONTIERS IN ONCOLOGY (2017)
NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells
Bruno R. B. Pires et al.
PLOS ONE (2017)
Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity
Cheng-Wei Yang et al.
SCIENTIFIC REPORTS (2017)
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
Laura D'Ignazio et al.
BIOMEDICINES (2017)
A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level
Raghu Erapaneedi et al.
EMBO JOURNAL (2016)
One microenvironment does not fit all: heterogeneity beyond cancer cells
Ik Sun Kim et al.
CANCER AND METASTASIS REVIEWS (2016)
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
Jing Xie et al.
MEDICAL ONCOLOGY (2016)
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
Xiaosheng Wang et al.
MEDICINE (2016)
The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts
Siti-Fauziah Hendrayani et al.
ONCOTARGET (2016)
Phenanthroindolizidine alkaloids from Tylophora atrofolliculata with hypoxia-inducible factor-1 (HIF-1) inhibitory activity
Cheng-Yu Chen et al.
RSC ADVANCES (2016)
G-Quadruplex DNA-binding quaternary alkaloids from Tylophora atrofolliculata
Cheng-Yu Chen et al.
RSC ADVANCES (2016)
Tylophorine Analog DCB-3503 Inhibited Cyclin D1 Translation through Allosteric Regulation of Heat Shock Cognate Protein 70
Ying Wang et al.
SCIENTIFIC REPORTS (2016)
Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Jian Wen et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Nirmala Chandralega Kampan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Expression of Nuclear Factor Kappa B (NF-κB) as a Predictor of Poor Pathologic Response to Chemotherapy in Patients with Locally Advanced Breast Cancer
Yan Wisnu Prajoko et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer
Ritu Arora et al.
PLOS ONE (2014)
NF-κB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression
Shannon M. Smith et al.
PLOS ONE (2014)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
c-Jun-mediated anticancer mechanisms of tylophorine
Cheng-Wei Yang et al.
CARCINOGENESIS (2013)
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Shuhui Lim et al.
DEVELOPMENT (2013)
Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells
Christina Befani et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells
Tsutomu Yoshida et al.
LABORATORY INVESTIGATION (2013)
Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis
Sarita Saraswati et al.
MOLECULAR CANCER (2013)
Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation
A. Notte et al.
CELL DEATH & DISEASE (2013)
Bioactive constituents from toxic seed plants in China
Jing Qu et al.
RSC ADVANCES (2013)
A new phenanthroindolizidine alkaloid from Tylophora indica
Mini Dhiman et al.
CHEMICAL PAPERS (2013)
Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs
Micah J. Niphakis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
The prognostic value of tumour-stroma ratio in triple-negative breast cancer
A. M. Moorman et al.
EJSO (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Aurora B kinase phosphorylates and instigates degradation of p53
Chris P. Gully et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities
Takashi Ikeda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Interaction Studies of an Anticancer Alkaloid, (+)-(13aS)-Deoxytylophorinine, with Calf Thymus DNA and Four Repeated Double-Helical DNAs
Zhenjia Liu et al.
CHEMOTHERAPY (2011)
Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids
Zhen-Jia Liu et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2011)
Efficient and Chirally Specific Synthesis of Phenanthro-Indolizidine Alkaloids by Parham-Type Cycloacylation
Ziwen Wang et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2010)
DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism
Ying Wang et al.
PLOS ONE (2010)
Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression
Chia-Mao Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Phenanthrene-Based Tylophorine-1 (PBT-1) Inhibits Lung Cancer Cell Growth through the Akt and NF-κB Pathways
Jau-Chen Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Total synthesis of phenanthroindolizidine alkaloids (+/-)-antofine, (+/-)-deoxypergularinine, and their dehydro congeners and evaluation of their cytotoxic activity
Chung-Ren Su et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Breast carcinoma - Associated fibroblasts and their counterparts display neoplastic-specific changes
Nahed M. Hawsawi et al.
CANCER RESEARCH (2008)
Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis
Peter Vaupel
ONCOLOGIST (2008)
Iron(III) chloride-based mild synthesis of phenanthrene and its application to total synthesis of phenanthroindolizidine alkaloids
Kai-Liang Wang et al.
TETRAHEDRON (2008)
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents
Wenli Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
Xiaobo Wang et al.
NATURE CELL BIOLOGY (2007)
Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503
Her-Shyong Shiah et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids
CW Yang et al.
MOLECULAR PHARMACOLOGY (2006)
Cytotoxic alkaloids from the roots of Tylophora atrofolliculata
XS Huang et al.
PLANTA MEDICA (2004)
Novel mode of action of tylophorine analogs as antitumor compounds
WL Gao et al.
CANCER RESEARCH (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
K Vermeulen et al.
CELL PROLIFERATION (2003)
Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α
Y Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine:: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents
KN Rao et al.
TOXICOLOGY IN VITRO (2000)
分享论文
